Back
AbbVie, Inc. Stock Predictions
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
60
ABBV
AbbVie, Inc.
Last Price:
$223.73
Seasonality Move:
5.27%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.AbbVie, Inc. Stock Forecast
-
Over the next 52 weeks, AbbVie, Inc. has on average historically risen by 16.9% based on the past 13 years of stock performance.
-
AbbVie, Inc. has risen higher in 11 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 84.62%
-
Is AbbVie, Inc. Stock Undervalued?The current AbbVie, Inc. [ABBV] share price is $223.26. The Score for ABBV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will AbbVie, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, AbbVie, Inc. has on average historically risen by 16.9% based on the past 13 years of stock performance.
AbbVie, Inc. Stock Rating
Buy
60
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. overpriced?
-
AbbVie, Inc. has risen higher in 11 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 84.62%
AbbVie, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
abbvie.com
52-Week Data
52-Week High:
244.81
52-Week Low:
164.39
Prediction Charts
Market Cap:
394.6B
Price in USD:
223.26
Volume:
6.8M
Beta:
0.74
Technical Analysis
SMA50:
223.85
SMA100:
225.57
SMA200:
209.88
52-Wk Change:
17.14%
Stock Predictions
-
Is AbbVie, Inc. stock public?Yes, AbbVie, Inc. is a publicly traded company.
-
What is the AbbVie, Inc. stock quote today?The AbbVie, Inc. stock price is 223.26 USD today.
-
How to buy AbbVie, Inc. stock online?You can buy AbbVie, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-21 | 212.47 | 216.15 | 218.00 | 211.57 |
| Jan-22 | 216.28 | 218.11 | 219.05 | 214.76 |
| Jan-23 | 217.26 | 219.26 | 219.82 | 215.88 |
| Jan-26 | 219.11 | 220.77 | 221.48 | 218.50 |
| Jan-27 | 220.88 | 223.93 | 226.86 | 220.65 |
| Jan-28 | 223.60 | 218.67 | 224.03 | 216.70 |
| Jan-29 | 218.00 | 220.43 | 224.14 | 218.00 |
| Jan-30 | 220.51 | 223.01 | 224.02 | 219.56 |
| Feb-2 | 224.85 | 225.64 | 229.79 | 224.42 |
| Feb-3 | 223.95 | 225.66 | 228.70 | 223.64 |
| Feb-4 | 209.78 | 217.11 | 220.85 | 204.27 |
| Feb-5 | 216.90 | 219.02 | 219.87 | 214.04 |
| Feb-6 | 218.75 | 223.43 | 225.82 | 218.50 |
| Feb-9 | 223.42 | 223.26 | 223.96 | 220.12 |
AbbVie, Inc. Earnings
AbbVie, Inc. Earnings Report: Per Share AbbVie, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
AbbVie, Inc. Forecast Revenue Growth
AbbVie, Inc. Stock Analysis: Historical quarterly revenues per share for AbbVie, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.43 per share, a decrease next quarter of $0.59 per share, an increase this year of $4.63 per share, and an increase next year of $1.42 per share.
* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.